RESOURCES
Dr. Busch Speaks with Atlanta Business RadioX
Atlanta Business RadioX Interview with Dr. Joe Busch Listen as Dr. Busch talks with Lee Cantor from Atlanta Business RadioX about how the three most common methods to detect prostate cancer are fraught with problems and errors. In the U.S., medical teams typically use either prostate-specific antigen (PSA) blood tests, blind needle biopsies, or digital rectal exams to determine whether a man has prostate cancer. Dr. Busch says these methods are...
Busch Center Uses the Safest, Most Stable Contrast Dye and Only When Necessary
At Busch Center, many of our scans and screenings are done with noneedles, contrast dye, or radiation for a more comfortable patient experience. In some cases, however, our magnetic resonance imaging (MRI) scans require us to use contrast agents to get a more robust view to see if (and where) cancer is located in the body. In the cases where contrast dye is necessary, we opt to use Dotarem because it’s the best, safest, most stable, and...
Agent Orange: Likely a Prostate Cancer Risk Factor
Research shows that exposure to Agent Orange, an herbicide frequently used during the Vietnam War, likely caused an aggressive form of prostate cancer in many Vietnam veterans. The U.S. military used significant amounts of Agent Orange, which was contaminated with dioxin, a dangerous toxin that is now believed to cause cancer, to spray on trees and other vegetation. Soldiers who served in Vietnam between 1962-1975 were likely exposed to this...
PSA Screenings: A Good Idea at Any Age
What is PSA? The prostate makes a protein called prostate-specific antigen (PSA), which is measured by a blood test. If the PSA is high, the patient may have prostate cancer, but other factors (including an enlarged prostate or certain medications) can also cause elevated numbers. How are PSA Screenings Helpful? Prostate cancer is the most common form of cancer in men, besides skin cancer. Research shows that 1 in 9 men will be...
My Prostate Cancer Journey: An Interview with John
Watch Busch Center patient, John, and his wife, April, share John's battle with prostate cancer, what they wish they would have known from the beginning, and their advice to men and their loved ones.
Transurethral Ultrasound Ablation (TULSA) for Prostate Cancer Treatment: An Interview With Joseph J. Busch, Jr., MD
Dr Busch was recently interviewed by IO Learning about integrating the recently FDA-approved TULSA treatment into his practice. He explained that in the phase 2 trial ... "They treated the entire gland with TULSA, and compared it with prostatectomy, with 4-year data now available. First, they’ve shown that they can kill cancer with this technique. Second, and very importantly, they’ve shown that 90% of the men who had sexual function before the...
Incision-Free, Radiation-Free Prostate Cancer Treatment Now Available in Georgia
ALPHARETTA, GA. (PRWEB) MARCH 25, 2020 Busch Center First in State to Offer Groundbreaking TULSA Procedure Busch Center, the leading prostate MRI facility in America, is now offering a groundbreaking cancer treatment procedure, known as the TULSA (Transurethral Ultrasound Ablation) Procedure, which requires no incision, no radiation and is customized to treat only unhealthy prostate tissue. Busch Center is one of the few elite facilities...
INFOGRAPHIC: Prostate Cancer in America
Know Before You Know Prostate cancer is the second most common cancer in men today. Just like mammograms are essential for women’s health, proactive prostate MRI screenings saves lives and improves the quality of life for men and their loved ones. Prostate Cancer in America at a Glance 191,930 Estimated new cases in 2020 104.2* Incidence Rates 2012-2016 33,330 Estimated deaths in 2020 19.1* Death Rates 2013-2017 2.9% Probability of dying...